Relationship between Serum Total Testosterone Concentration and Metabolic Syndrome in Premenopausal Obese Women
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Men with low testosterone levels are at an increased risk of developing metabolic syndrome, irrespective of age or obesity. However, the relationship between metabolic syndrome and testosterone levels in women remains unclear. We compared the total testosterone concentrations between premenopausal obese women with and without metabolic syndrome and identified the factors affecting these concentrations. Methods: A single-center retrospective analysis was conducted using the medical records of 580 premenopausal women with obesity. The diagnostic criteria for metabolic syndrome were established using the National Cholesterol Education Program Adult Treatment Panel III guidelines. Results: The mean±standard deviation age, weight, and body mass index were 38.8±8.4 years, 78.0±11.8 kg, and 30.0±4.1 kg/m2, respectively. The mean total testosterone concentration was lower in the metabolic syndrome group than in the non-metabolic syndrome group (n=385 vs. n=195; 0.22±0.10 ng/mL vs. 0.24±0.11 ng/mL; P<0.001). In a model adjusted for age, body mass index, skeletal muscle mass, body fat mass, and body fat percentage, the odds ratio for metabolic syndrome with respect to the total testosterone level was 0.128 (P=0.028). Testosterone concentration was negatively correlated with age (r=-0.334), systolic blood pressure (r=-0.084), and triglyceride concentration (r=-0.093) but positively correlated with weight (r=0.144), body mass index (r=0.140), waist circumference (r=0.133), body fat mass (r=0.167), and body fat percentage (r=0.167). Stepwise regression analysis revealed that age (β=-0.004, P<0.001), body mass index (β=0.003, P=0.004), and high-density lipoprotein cholesterol concentration (β=0.001, P=0.019) were independently associated with total testosterone concentration (adjusted R2=12.6%). Conclusion: Metabolic syndrome and obesity may be independently associated with testosterone levels in premenopausal women with obesity.
Abstract
Background: Men with low testosterone levels are at an increased risk of developing metabolic syndrome, irrespective of age or obesity. However, the relationship between metabolic syndrome and testosterone levels in women remains unclear. We compared the total testosterone concentrations between premenopausal obese women with and without metabolic syndrome and identified the factors affecting these concentrations. Methods: A single-center retrospective analysis was conducted using the medical records of 580 premenopausal women with obesity. The diagnostic criteria for metabolic syndrome were established using the National Cholesterol Education Program Adult Treatment Panel III guidelines. Results: The mean±standard deviation age, weight, and body mass index were 38.8±8.4 years, 78.0±11.8 kg, and 30.0±4.1 kg/m2, respectively. The mean total testosterone concentration was lower in the metabolic syndrome group than in the non-metabolic syndrome group (n=385 vs. n=195; 0.22±0.10 ng/mL vs. 0.24±0.11 ng/mL; P<0.001). In a model adjusted for age, body mass index, skeletal muscle mass, body fat mass, and body fat percentage, the odds ratio for metabolic syndrome with respect to the total testosterone level was 0.128 (P=0.028). Testosterone concentration was negatively correlated with age (r=-0.334), systolic blood pressure (r=-0.084), and triglyceride concentration (r=-0.093) but positively correlated with weight (r=0.144), body mass index (r=0.140), waist circumference (r=0.133), body fat mass (r=0.167), and body fat percentage (r=0.167). Stepwise regression analysis revealed that age (β=-0.004, P<0.001), body mass index (β=0.003, P=0.004), and high-density lipoprotein cholesterol concentration (β=0.001, P=0.019) were independently associated with total testosterone concentration (adjusted R2=12.6%). Conclusion: Metabolic syndrome and obesity may be independently associated with testosterone levels in premenopausal women with obesity.
참고문헌 (30)
- "Obesity and overweight" (2016)[URL]
- Singh GM, "The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes : a pooled analysis", PLoS One, 8, pp.e65174~ (2013)
- Lauby-Secretan B, "Body fatness and cancer : viewpoint of the IARC Working Group", N Engl J Med, 375, pp.794~798 (2016)
- The 8th Korea National Health and Nutrition Examination Survey (3rd year), "Korea Disease Control and Prevention Agency", Korea Disease Control and Prevention Agency, ~
- Mazur A, "Testosterone and dominance in men", Behav Brain Sci, 21, pp.353~397 (1998)
- Kelly DM, "Testosterone and obesity", Obes Rev, 16, pp.581~606 (2015)
- Wang C, "Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes", Diabetes Care, 34, pp.1669~1675 (2011)
- Allan CA, "Androgens and obesity", Curr Opin Endocrinol Diabetes Obes, 17, pp.224~232 (2010)
- MacDonald AA, "The impact of body mass index on semen parameters and reproductive hormones in human males : a systematic review with meta-analysis", Hum Reprod Update, 16, pp.293~311 (2010)
- Brand JS, "Testosterone, sex hormone-binding globulin and the metabolic syndrome : a systematic review and meta-analysis of observational studies", Int J Epidemiol, 40, pp.189~207 (2011)
- Pasquali R, "Obesity and androgens : facts and perspectives", Fertil Steril, 85, pp.1319~1340 (2006)
- Liang J, "The association between serum testosterone levels and metabolic syndrome among women", Diabetol Metab Syndr, 13, pp.26~ (2021)
- Fatani SH, "Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women", Diabetes Metab Syndr Obes, 11, pp.175~181 (2018)
- Korhonen S, "The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women : a controlled community-based study", Fertil Steril, 79, pp.1327~1334 (2003)
- Taylor HS, "Speroff’s clinical gynecologic endocrinology and infertility" (2019), Lippincott Williams &Wilkins
- Lee S, "Cut-off points of waist circumference for defining abdominal obesity in the Korean population", Korean J Obes, 15, pp.1~9 (2006)
- Pitteloud N, "Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men", Diabetes Care, 28, pp.1636~1642 (2005)
- Hong SM, "Correlation of serum total testosterone with obesity and metabolic syndrome in premenopausal and postmenopausal women", J Korean Soc Study Obes, 13, pp.300~307 (2004)
- Sowers MF, "Testosterone concentrations in women aged 25-50 years : associations with lifestyle, body composition, and ovarian status", Am J Epidemiol, 153, pp.256~264 (2001)
- Zumoff B, "Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women", J Clin Endocrinol Metab, 80, pp.1429~1430 (1995)
- Makinen JI, "Endogenous testosterone and serum lipids in middle-aged men", Atherosclerosis, 197, pp.688~693 (2008)
- Traish AM, "Testosterone and weight loss : the evidence", Curr Opin Endocrinol Diabetes Obes, 21, pp.313~322 (2014)
- Pasquali R, "Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity", Int J Obes(Lond), 32, pp.1764~1779 (2008)
- Tsai EC, "Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men", Int J Obes Relat Metab Disord, 24, pp.485~491 (2000)
- Pitteloud N, "Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men", J Clin Endocrinol Metab, 90, pp.2636~2641 (2005)
- Wu FC, "Androgens and coronary artery disease", Endocr Rev, 24, pp.183~217 (2003)
- Nestler JE, "Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system", J Clin Endocrinol Metab, 83, pp.2001~2005 (1998)
- Moran C, "The role of the adrenal cortex in polycystic ovary syndrome", Obstet Gynecol Clin North Am, 28, pp.63~75 (2001)
- Kirschner MA, "Androgen-estrogen metabolism in women with upper body versus lower body obesity", J Clin Endocrinol Metab, 70, pp.473~479 (1990)
- Lindstedt G, "Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM : 12-yr follow-up of population study of women in Gothenburg, Sweden", Diabetes, 40, pp.123~128 (1991)